These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27834955)

  • 1. Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.
    Vila MC; Rayavarapu S; Hogarth MW; Van der Meulen JH; Horn A; Defour A; Takeda S; Brown KJ; Hathout Y; Nagaraju K; Jaiswal JK
    Cell Death Differ; 2017 Feb; 24(2):330-342. PubMed ID: 27834955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
    Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
    Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle.
    Murphy S; Zweyer M; Henry M; Meleady P; Mundegar RR; Swandulla D; Ohlendieck K
    J Proteomics; 2019 Jan; 191():212-227. PubMed ID: 29408692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.
    Kim MH; Kay DI; Rudra RT; Chen BM; Hsu N; Izumiya Y; Martinez L; Spencer MJ; Walsh K; Grinnell AD; Crosbie RH
    Hum Mol Genet; 2011 Apr; 20(7):1324-38. PubMed ID: 21245083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy.
    Timpani CA; Goodman CA; Stathis CG; White JD; Mamchaoui K; Butler-Browne G; Gueven N; Hayes A; Rybalka E
    Sci Rep; 2020 Jan; 10(1):1125. PubMed ID: 31980663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Mikheeva IB; Sharapov MG; Belosludtsev KN
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165674. PubMed ID: 31926263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
    Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
    Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
    Barker RG; Wyckelsma VL; Xu H; Murphy RM
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular matrix differentially directs myoblast motility and differentiation in distinct forms of muscular dystrophy: Dystrophic matrices alter myoblast motility.
    Long AM; Kwon JM; Lee G; Reiser NL; Vaught LA; O'Brien JG; Page PGT; Hadhazy M; Reynolds JC; Crosbie RH; Demonbreun AR; McNally EM
    Matrix Biol; 2024 May; 129():44-58. PubMed ID: 38582404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Absence of Dystrophin Expression Exacerbates Ectopic Myofiber Calcification and Fibrosis and Alters Macrophage Infiltration Patterns.
    Young CNJ; Gosselin MRF; Rumney R; Oksiejuk A; Chira N; Bozycki L; Matryba P; Łukasiewicz K; Kao AP; Dunlop J; Robson SC; Zabłocki K; Górecki DC
    Am J Pathol; 2020 Jan; 190(1):190-205. PubMed ID: 31726040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
    Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K
    PLoS One; 2013; 8(7):e66617. PubMed ID: 23843959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
    Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
    Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
    Negishi Y; Ishii Y; Shiono H; Akiyama S; Sekine S; Kojima T; Mayama S; Kikuchi T; Hamano N; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    Mol Pharm; 2014 Mar; 11(3):1053-61. PubMed ID: 24433046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.